Retrieved from WHO
Winther KH, Rayman MP, Bonnema SJ, Hegeds L (2020) Selenium in thyroid disorders - essential knowledge for clinicians
only, and this is going to be interesting to see because not only biosimilars are going to be introduced in 2023, but theres going to be multiple biosimilars of Humira introduced this year
Oral tirzepatide is an innovative oral medication for weight loss that combines GLP-1 and GIP activity in a daily pill
These conditions tend to include: underactive thyroid (hypothyroidism) type 2 diabetes menopause Cushing disease polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) genetic conditions, like Prader-Willi syndrome If you havent already received a diagnosis, an endocrinologist can determine whether weight gain is from hormonal changes, such as too much or too little of a certain hormone
Drucker began his journey studying genetic sequencing of glucagon-like peptides at a lab in Boston in the 1980s, then returned to Canada and continued his work at the University of Toronto
